Search results
AstraZeneca admits Covid-19 vaccine may cause blood clots in “very rare” cases
Pharmaceutical Technology via Yahoo Finance· 5 days agoAstraZeneca has been embroiled in a class action lawsuit for itsCovid-19 vaccine, admitting that the...
BioNTech's Outlook Gives Vaccine Maker a Shot in the Arm
Investopedia· 16 hours agoAmerican depositary receipts (ADRs) of BioNTech (BNTX) were down less than 1% in intraday trading...
mRNA Vaccines: Not Just for COVID Soon?
Medscape· 5 days agoTo date, mRNA vaccines have had their largest global presence in combating the COVID-19 pandemic. Intensive research is underway on many ...
GAO report shows SNS challenges during COVID, mpox
Center for Infectious Disease Research and Policy· 3 hours agoIn fact, 35% of jurisdictions during COVID-19 and 30% during mpox said the process for requesting SNS inventory did not follow written guidelines.
What's Going With BioNTech Stock On Monday?
Benzinga via Yahoo Finance· 7 hours agoMonday, BioNTech SE (NASDAQ:BNTX) reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the...
Shah Capital urges Novavax shareholders to vote against three directors
Reuters via AOL· 11 hours ago(Reuters) -Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the...
Protection against COVID-19 strains that have not yet emerged — and more
WGN TV Chicago· 1 hour agoFor Monday, May 6, WGN’s Dina Bair has the latest on new medical information.
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 4 days agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...
Supreme Court Rejects Military Chaplains' Lawsuit Claiming Refusal of COVID-19 Vaccine Hurt Their...
Military.com· 7 days agoThe U.S. Supreme Court has decided not to hear a case involving 39 military chaplains who say they...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
AOL· 4 days agoThe dark days of the pandemic are finally in the past for most of us—and that seems to be reflected in the earnings for Moderna, whose revenue is dependent on sales of its COVID< ...
